This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Iontas Limited. Active years: 2022-2024.
Company Filing History:
Years Active: 2022-2024
Title: Kothai Parthiban: Innovator in Eukaryotic Cell Libraries
Introduction
Kothai Parthiban is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biotechnology, particularly in the development of methods for producing eukaryotic cell libraries. With a total of four patents to her name, her work focuses on enhancing the selection of binding molecules through innovative techniques.
Latest Patents
One of her latest patents is titled "Preparation of libraries of protein variants expressed in eukaryotic cells and use for selecting binding molecules." This invention relates to methods of producing eukaryotic cell libraries that encode a repertoire of binding molecules, known as 'binders.' The methods utilize a site-specific nuclease for targeted cleavage of cellular DNA, which enhances the site-specific integration of binder genes through endogenous cellular repair mechanisms. As a result, populations of eukaryotic cells are created, integrating a repertoire of genes encoding binders into a desired locus in cellular DNA. This allows for the expression of the encoded binding molecules, ultimately leading to a diverse population of cells expressing different binders.
Career Highlights
Kothai Parthiban is currently employed at Iontas Limited, where she continues to advance her research and innovations. Her work has been instrumental in the development of new methodologies that have the potential to revolutionize the field of protein engineering and therapeutic development.
Collaborations
Throughout her career, Kothai has collaborated with notable colleagues, including John Gerald McCafferty and Michael Richard Dyson. These collaborations have further enriched her research and contributed to the success of her innovative projects.
Conclusion
Kothai Parthiban is a trailblazer in the field of biotechnology, with her innovative patents paving the way for advancements in eukaryotic cell libraries. Her contributions are significant and continue to impact the scientific community positively.